CLSI - CAP26
Navigating Antifungal Susceptibility Testing: ECVs, Taxonomy and Emerging Resistance Challenges
Fungal pathogens continue to evolve, creating new challenges for laboratories responsible for susceptibility testing, result interpretation, and clinical reporting. Join experts from the College of American Pathologists (CAP) and the Clinical and Laboratory Standards Institute (CLSI) for a timely discussion on emerging resistance trends, evolving fungal taxonomy, and practical approaches to antifungal susceptibility testing. The session will explore current challenges affecting clinical laboratories and their impact on patient care.
Through real-world examples and expert perspectives, attendees will gain practical insights into the use of ECVs, common reporting considerations, and current guidance for interpreting and reporting fungal susceptibility results. This webinar will provide actionable strategies to help you navigate testing complexities, apply best practices with confidence, and stay current in one of the most rapidly evolving areas of clinical microbiology.
This webinar is intended for:
- Clinical Microbiologists
- Medical Laboratory Scientists
- Laboratory Managers and Directors
Date: 29 October 2026 | 1:00 - 2:00 PM EDT
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceLearning Objectives
- Use case-based examples to describe current challenge and emerging issues in antifungal susceptibility testing
- Apply CAP and CLSI guidance to the interpretation and reporting of fungal susceptibility testing results.
- Recognize the impact of evolving fungal taxonomy and resistance patterns on clinical laboratory practice
- Discuss common reporting considerations and pitfalls encountered in medical mycology laboratories.
Intermediate: Refresher course. Some basic knowledge required; for staff technologists with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
CLSI M100
Free
CLSI M02
Free
Learning Objectives
- Use case-based examples to describe current challenge and emerging issues in antifungal susceptibility testing
- Apply CAP and CLSI guidance to the interpretation and reporting of fungal susceptibility testing results.
- Recognize the impact of evolving fungal taxonomy and resistance patterns on clinical laboratory practice
- Discuss common reporting considerations and pitfalls encountered in medical mycology laboratories.
Intermediate: Refresher course. Some basic knowledge required; for staff technologists with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.